Overview

Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
0
Participant gender:
All
Summary
To compare the safety and effectiveness of oculusgen (ologen) collagen matrix implantation and Mitomycin-C(MMC) in glaucoma surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pro Top & Mediking Company Limited
Treatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:

- Open angle glaucoma

- Maxima anti-glaucoma medication failed

- Age>18

- Able to complete the follow up

Exclusion Criteria:

- Topical eye inflammation

- Angle closure glaucoma

- Deformity glaucoma

- One eye glaucoma

- Previous conjunctiva opened

- Allergy to collagen